2011 Scrip 100: On the drug lag and serving Japan
This article was originally published in Scrip
Executive Summary
The Democratic Party of Japan has taken an axe to many areas of public spending, but the country's medicines regulator has emerged relatively unscathed. In fact, the PMDA continues to increase its headcount to help cut the delay in delivering novel medicines to Japanese patients, the agency's Dr Tatsuya Kondo and Dr Hideo Utsumi tell Ian Haydock.